Investors lose appetite for the obesity trade
Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new drug last month and ...
hims & hers CEO Andrew Dudum sells shares worth $438,184
Andrew Dudum, the Chief Executive Officer of Hims & Hers Health, Inc. (NYSE:HIMS), recently executed a series of stock transactions, according to a Form 4 filing with the Securities and Exchange ...